Fig. 2From: Possible involvement of interleukin-18 in the pathology of hepatobiliary adverse effects related to treatment with ceritinibRepresentative photographs of immunocytochemical staining against IL-18. A portion of the liver tissue from the liver biopsy was also immunostained with antibody to IL-18 (brown; arrows), and the nuclei were identified with hematoxylin-eosin stain (× 100). Bar, 200 μm. In the window, a high magnification image (× 200) is shown. IL-18 positive cells were detected in the inflammatory sites around the interlobular bile duct of the liver tissueBack to article page